Otsuka Holdings
4578.T
#676
Rank
โ‚น2.526 T
Marketcap
โ‚น4,665
Share price
0.00%
Change (1 day)
50.53%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2024 (TTM): โ‚น81.50 B

According to Otsuka Holdings 's latest financial reports the company's current earnings (TTM) are โ‚น82.04 B. In 2023 the company made an earning of โ‚น88.15 B a decrease over its 2022 earnings that were of โ‚น111.34 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น81.50 B-7.55%
2023 โ‚น88.15 B-20.82%
2022 โ‚น111.34 B-13.04%
2021 โ‚น128.04 B-19.69%
2020 โ‚น159.44 B13.78%
2019 โ‚น140.14 B52.13%
2018 โ‚น92.12 B11.32%
2017 โ‚น82.75 B-36.26%
2016 โ‚น129.83 B31.64%
2015 โ‚น98.62 B
2013 โ‚น205.23 B33.73%
2012 โ‚น153.46 B-4.78%
2011 โ‚น161.16 B46.23%
2010 โ‚น110.21 B